Panel Discussion: Navigating Global Regulatory Challenges in Cell & Gene Therapy
Time: 3:30 pm
day: Conference Day One- pt 2
Details:
• Diverging Regulatory Pathways: Understanding key differences in regulatory requirements between the FDA, EMA, and other global regulators in cell and gene therapy
• Exploring ongoing initiatives for global regulatory convergence and the impact on innovation and patient access
• Perspectives from regulators in the U.S., EU, Asia, and other countries on navigating local challenges and fostering international collaboration
